Peter Elliott

Stocks To Watch: Agenus Inc. (AGEN), Fitbit, Inc. (FIT), Coeur Mining, Inc. (CDE)

Agenus Inc. (AGEN) traded within a range of $4.23 to $4.78 after opening the day at $4.6. The company has seen its stock increase in value by 6.8% so far this year. The stock was up close to 6.8% on active volume in last trading session and closed at $4.4 per share. After the recent gain, the stock is currently holding -41.26% below its 52 week high of $7.49 and 66.04% above its 12-month low of $2.65. The shares are down by over -18.06% in the last three months, and the RSI indicator value of 63.13 is neither bullish nor bearish, tempting investors to stay on the sidelines.

Agenus Inc., an immuno-oncology company, focuses on the discovery and development of treatments that engage the body’s immune system for patients suffering with cancer. The company offers Retrocyte Display, an antibody discovery platform that screens and generates therapeutic antibody drug candidates using a high-throughput approach incorporating human antibody libraries expressed in mammalian B-lymphocytes. It is also developing Prophage, a heat shock protein-based autologous vaccine, which has completed Phase II clinical trials for the treatment of glioblastoma; and QS-21 Stimulon, a saponin-based vaccine adjuvant that has completed Phase III clinical trials for the treatment of malaria and shingles. The company’s preclinical development products include AutoSynVax, a neo-antigen based vaccine targeting the neo-epitope landscape in cancer patients; PhosphoSynVax, a vaccine candidate designed to induce immunity against a novel class of tumor specific neo-epitopes; and checkpoint modulator product candidates targeting GITR, OX40, CTLA-4, LAG-3, TIM-3, PD-1, CEACAM1, and other undisclosed targets. The company was formerly known as Antigenics Inc. and changed its name to Agenus Inc. in January 2011. Agenus Inc. was founded in 1994 and is headquartered in Lexington, Massachusetts.

Fitbit, Inc. (FIT) managed to rebound with the stock climbing 2.27% or $0.13 to close the day at $5.86 on active trading volume of 6.41M shares, compared to its three month average trading volume of 11.12M. The San Francisco California 94105 based company has been underperforming the scientific & technical instruments group over the past 52 weeks, with the stock losing -60.67%, compared to the industry which has advanced 43.73% over the same period. With RSI of 33.26, the stock should still continue to rise and get closer to its one year target estimate of $8, making it a hold for now.

Fitbit, Inc. provides wearable health and fitness tracking devices. It offers various products, including Fitbit Zip, an entry-level wireless tracker that allows users to track daily activity statistics, such as steps, distance, calories burned, and active minutes; Fitbit One, a clippable wireless tracker, which tracks floors climbed and sleep, as well as daily steps, distance, calories burned, and active minutes; Fitbit Flex, a wristband-style tracker that tracks steps, distance, calories burned, active minutes, and sleep; and Fitbit Charge, an activity and sleep wristband, which tracks steps, distance, calories burned, active minutes, floors climbed, and sleep. The company also provides Fitbit Alta, a customizable wristband that offers call, text, and calendar notifications when paired with the user’s phone and SmartTrack automatic exercise recognition; and Fitbit Charge HR, a wireless heart rate and activity wristband. In addition, it offers Fitbit Blaze, a smart fitness watch that provides multi-sport functionality, tracks outdoor cycling activity, and provides run cues; Fitbit Surge, a fitness watch that features a GPS watch, heart rate tracker, activity tracker, and smartwatch; Aria, a Wi-Fi connected scale that tracks weight, body fat percentage, and body mass index; and Fitbit accessories that include bands and frames for Fitbit Blaze, bands for Fitbit Alta, colored bands for Fitbit Flex, colored clips for Fitbit One and Fitbit Zip, device charging cables, wireless sync dongles, band clasps, sleep bands, and Fitbit apparel. The company offers its products through consumer electronics and specialty retailers, e-Commerce retailers, sporting goods and outdoors retailers, and wireless carriers; and corporate wellness channels, as well as directly worldwide. The company was formerly known as Healthy Metrics Research, Inc. and changed its name to Fitbit, Inc. in October 2007. Fitbit, Inc. was founded in 2007 and is headquartered in San Francisco, California.

Coeur Mining, Inc. (CDE) dropped $-0.06 to close the day at a new closing price of $9.32, a -0.64% decrease in value from its previous closing price that moved the stock 201.62% above its 52 week low of $3.17. A total of 5.61M shares exchanged hands during the day compared with its three month average trading volume of 4.19M. The stock, which fluctuated between $9.2 and $9.79 during the day, currently situated -43.21% below its 52 week high. The stock is down by -18.17% in the past one month and up by 1.86% over the past three months. With a one year target estimate of $12.83 and RSI of 34.32, the stock still has upside potential, making it a hold for now.

Coeur Mining, Inc. owns, operates, explores for, and develops silver and gold properties. The company holds interests in the Palmarejo silver and gold mine located in Mexico; the Rochester silver and gold mine in northwestern Nevada; the Kensington gold mine located to the north of Juneau, Alaska; and the Wharf gold mine in South Dakota. It also owns interests in the San Bartolomé silver mine in Bolivia; the Endeavor zinc, lead, and silver mine located in Australia; the La Preciosa silver-gold exploration project in the State of Durango, Mexico; and the Joaquin silver-gold exploration project located in the Santa Cruz province of southern Argentina. Coeur Mining, Inc. markets its silver and gold concentrates to third-party refiners and smelters in the United States, China, and Japan. The company was formerly known as Coeur d’Alene Mines Corporation and changed its name to Coeur Mining, Inc. in May 2013. Coeur Mining, Inc. was founded in 1928 and is based in Chicago, Illinois.

 

Stocks To Track: KB Home (KBH), Depomed, Inc. (DEPO), Peregrine Pharmaceuticals, Inc. (PPHM)

KB Home (KBH) fell -1.53% during last trading as the stock lost $-0.25 to finish the day at $16.11 with about 2.22M shares changing hands, compared to its three month average trading volume of 2.46M. The $1.35B market cap company, which fluctuated between $16.03 and $16.38 during the day, currently situated 58.37% above its 52 week low of $10.59 and -7.17% away from its one year high of $17.38. The RSI of 44.31 indicates the stock is neither overvalued nor undervalued at the current levels, hold for now.

KB Home operates as a homebuilding company in the United States. It builds and sells various homes, including attached and detached single-family residential homes, townhomes, and condominiums primarily for first-time, move-up, and active adult homebuyers. The company also provides property and casualty insurance, as well as earthquake, flood, and personal property insurance to its homebuyers; title services; and mortgage banking services, including residential mortgage loan originations to its homebuyers. It has operations in California, Arizona, Nevada, Colorado, Texas, Florida, and North Carolina, The company was formerly known as Kaufman and Broad Home Corporation and changed its name to KB Home in January 2001. KB Home was founded in 1957 and is headquartered in Los Angeles, California.

Depomed, Inc. (DEPO) dropped $-0.32 to close the day at a new closing price of $16.68, a -1.88% decrease in value from its previous closing price that moved the stock 36.16% above its 52 week low of $12.25. A total of 2.2M shares exchanged hands during the day compared with its three month average trading volume of 1.42M. The stock, which fluctuated between $16.05 and $16.8 during the day, currently situated -38.27% below its 52 week high. The stock is down by -11.65% in the past one month and down by -19.96% over the past three months. With a one year target estimate of $23.91 and RSI of 36.87, the stock still has upside potential, making it a hold for now.

Depomed, Inc., a specialty pharmaceutical company, engages in the development, sale, and licensing of products for pain and other central nervous system conditions in the United States. It offers Gralise (gabapentin), an once-daily product for the management of postherpetic neuralgia; CAMBIA (diclofenac potassium for oral solution), a non-steroidal anti-inflammatory drug indicated for acute treatment of migraine attacks in adults; Zipsor (diclofenac potassium) liquid filled capsule, a non-steroidal anti-inflammatory drug for the treatment of mild to moderate acute pain in adults; and Lazanda (fentanyl) nasal spray, an intranasal fentanyl drug used to manage breakthrough pain in adults. The company also provides NUCYNTA ER (tapentadol extended release tablets), a product for the management of pain severe enough to long term opioid treatment, including neuropathic pain associated with diabetic peripheral neuropathy (DPN) in adults; and NUCYNTA (tapentadol), a product for the management of moderate to severe acute pain in adults. In addition, it is involved in the clinical development of IW-3718 refractory gastroesophageal reflux disease program using Acuform drug delivery technology; and Cebranopadol, a molecule for the treatment of chronic nociceptive and neuropathic pain. Depomed, Inc. sells its Gralise products to wholesalers and retail pharmacies. The company also has a portfolio of license agreements based on its proprietary Acuform gastroretentive drug delivery technology with Mallinckrodt Inc.; Ironwood Pharmaceuticals, Inc.; and Janssen Pharmaceuticals, Inc. The company was founded in 1995 and is headquartered in Newark, California.

Peregrine Pharmaceuticals, Inc. (PPHM) had a active trading with around 2.2M shares changing hands compared to its three month average trading volume of 2.08M. The stock traded between $0.361 and $0.3825 before closing at the price of $0.37 with 0.76% change on the day. The Tustin California 92780 based company is currently trading 33.14% above its 52 week low of $0.282 and -66.71% below its 52 week high of $1.12. Both the RSI indicator and target price of 76.78 and $1.25 respectively, lead us to believe that it could drop over the coming weeks.

Peregrine Pharmaceuticals, Inc., a biopharmaceutical company, researches and develops monoclonal antibodies for the treatment of cancer in the United States. It’s lead immunotherapy candidate bavituximab, a monoclonal antibody that targets and binds to phosphatidylserine. The company also provides integrated current good manufacturing practices services from cell line development to commercial bio manufacturing for its third-party customers. In addition, its services comprise cGMP clinical and commercial manufacturing utilizing stainless steel and single use bioreactor technology, purification, bulk packaging, stability testing, regulatory strategy and related support. The company has license agreements with the University of Texas Southwestern Medical Center at Dallas; Genentech, Inc.; Avanir Pharmaceuticals, Inc.; Lonza Biologics; Affitech A/S; Merck KGaA; and National Comprehensive Cancer Network, as well as collaboration agreement with AstraZeneca PLC and Memorial Sloan Kettering Cancer Center. Peregrine Pharmaceuticals, Inc. was founded in 1981 and is headquartered in Tustin, California.

 

3 Trending Stocks: Devon Energy Corporation (DVN), EQT Corporation (EQT), EOG Resources, Inc. (EOG)

Devon Energy Corporation (DVN) managed to rebound with the stock climbing 1.5% or $0.68 to close the day at $45.94 on light trading volume of 3.36M shares, compared to its three month average trading volume of 4.41M. The Oklahoma City Oklahoma 73102 based company has been outperforming the independent oil & gas group over the past 52 weeks, with the stock gaining 119.37%, compared to the industry which has advanced 52.17% over the same period. With RSI of 50.34, the stock should still continue to rise and get closer to its one year target estimate of $53.11, making it a hold for now.

Devon Energy Corporation, an independent energy company, primarily engages in the exploration, development, and production of oil, natural gas, and natural gas liquids (NGLs) in the United States and Canada. It operates approximately 19,000 wells. The company also offers midstream energy services, including gathering, transmission, processing, fractionation, and marketing to producers of natural gas, NGLs, crude oil, and condensate through its natural gas pipelines, plants, and treatment facilities. Devon Energy Corporation was founded in 1971 and is headquartered in Oklahoma City, Oklahoma.

EQT Corporation (EQT) climbed 1.09% during last trading as the stock added $0.68 to finish the day at $63.21 with about 1.04M shares changing hands, compared to its three month average trading volume of 1.96M. The $10.82B market cap company, which fluctuated between $62.08 and $63.26 during the day, currently situated 16.73% above its 52 week low of $54.22 and -21.52% away from its one year high of $80.61. The RSI of 47.83 indicates the stock is neither overvalued nor undervalued at the current levels, hold for now.

EQT Corporation, together with its subsidiaries, operates as an integrated energy company in the United States. The company operates through three segments: EQT Production, EQT Gathering, and EQT Transmission. The EQT Production segment engages in the exploration for, development, and production of natural gas, natural gas liquids (NGLs), and crude oil primarily in the Appalachian Basin. As of December 31, 2016, this segment had 13.5 trillion cubic feet of proved natural gas, NGL, and crude oil reserves across approximately 3.6 million gross acres comprising approximately 790,000 gross acres in the Marcellus play. The EQT Gathering is involved in natural gas gathering activities. As of December 31, 2016, this segment operates approximately 300 miles of high pressure gathering lines with approximately 1.8 billion cubic feet of total firm gathering capacity and various interconnect points; and approximately 1,500 miles of FERC-regulated low pressure gathering lines. The EQT Transmission segment engages in natural gas transmission and storage activities. As of December 31, 2016, this segment operates approximately 950-mile FERC-regulated interstate pipeline that connects to six interstate pipelines and multiple distribution companies. EQT Corporation was founded in 1925 and is headquartered in Pittsburgh, Pennsylvania.

EOG Resources, Inc. (EOG) saw its value increase by 0.88% as the stock gained $0.88 to finish the day at a closing price of $101.23. The stock was higher in trading and has fluctuated between $62.53-$109.37 per share for the past year. The shares, which traded within a range of $99.02 to $101.48 during the day, are up by 10.92% in the past three months and up by 12.17% over the past six months. It is currently trading -0.8% below its 20 day moving average and -1.79% below its 50 day moving average. Analysts believe the company can continue to increase in value to reach at $112.56 a share over the next twelve months. The current relative strength index (RSI) reading is 47.72. The technical indicator lead us to believe there will be no major movement any time soon, hold.

EOG Resources, Inc., together with its subsidiaries, explores for, develops, produces, and markets crude oil and natural gas. The company’s principal producing areas are located in New Mexico, North Dakota, Texas, Utah, and Wyoming in the United States; and Canada, the Republic of Trinidad and Tobago, the United Kingdom, and the People’s Republic of China. As of December 31, 2015, it had total estimated net proved reserves of 2,118 million barrels of oil equivalent, including 1,098 million barrels (MMBbl) crude oil and condensate reserves; 383 MMBbl of natural gas liquid reserves; and 3,825 billion cubic feet of natural gas reserves. EOG Resources, Inc. was founded in 1985 and is headquartered in Houston, Texas.

 

Stocks Under Consideration: QUALCOMM Incorporated (QCOM), Biogen Inc. (BIIB), U.S. Bancorp (USB)

QUALCOMM Incorporated (QCOM) grew with the stock adding 1% or $0.55 to close at $55.48 on active trading volume of 13.06M compared its three months average trading volume of 11.87M. The San Diego California 92121 based company operating under the Communication Equipment industry has been trending up for the last 52 weeks, with the shares price now 22.97% up for the period and down by -14.91% so far this year. With price target of $65.53 and a 26.57% rebound from 52-week low, QUALCOMM Incorporated has plenty of upside potential, making it a hold with a view buy.

QUALCOMM Incorporated develops, designs, manufactures, and markets digital communications products and services in China, South Korea, Taiwan, the United States, and internationally. The company operates through three segments: Qualcomm CDMA Technologies (QCT); Qualcomm Technology Licensing (QTL); and Qualcomm Strategic Initiatives (QSI). The QCT segment develops and supplies integrated circuits and system software based on code division multiple access (CDMA), orthogonal frequency division multiple access (OFDMA), and other technologies for use in voice and data communications, networking, application processing, multimedia, and global positioning system products. The QTL segment grants licenses or provides rights to use portions of its intellectual property portfolio, which include various patent rights useful in the manufacture and sale of certain wireless products comprising products implementing CDMA2000, WCDMA, CDMA TDD, and/or LTE standards, as well as their derivatives. The QSI segment invests in early-stage companies in various industries, including digital media, e-commerce, healthcare, and wearable devices for supporting the design and introduction of new products and services for voice and data communications. The company also develops and offers products for implementation of small cells; mobile health products and services; software products, and content and push-to-talk enablement services to wireless operators; and development, and other services and related products to the United States government agencies and their contractors. In addition, it licenses chipset technology and products for data centers. QUALCOMM Incorporated was founded in 1985 and is headquartered in San Diego, California.

Biogen Inc. (BIIB) had a active trading with around 2.4M shares changing hands compared to its three month average trading volume of 1.8M. The stock traded between $279.01 and $286.06 before closing at the price of $285.14 with 2.23% change on the day. The Cambridge Massachusetts 02142 based company is currently trading 27.85% above its 52 week low of $223.02 and -14.54% below its 52 week high of $333.65. Both the RSI indicator and target price of  and $319.98 respectively, lead us to believe that it could rise over the coming weeks.

Biogen Inc., a biopharmaceutical company, discovers, develops, manufactures, and delivers therapies for the treatment of neurological and autoimmune diseases worldwide. The company offers TECFIDERA, AVONEX, PLEGRIDY, TYSABRI, ZINBRYTA, and FAMPYRA to treat multiple sclerosis (MS); FUMADERM for the treatment of plaque psoriasis; and SPINRAZA to treat spinal muscular atrophy. It also provides BENEPALI, an etanercept biosimilar referencing ENBREL; FLIXABI, an infliximab biosimilar referencing REMICADE; RITUXAN for the treatment of non-Hodgkin’s lymphoma, chronic lymphocytic leukemia (CLL), and other conditions; GAZYVA to treat CLL and follicular lymphoma; and other potential anti-CD20 therapies. The company’s Phase III clinical trial products comprise GAZYVA for the treatment of front-line indolent non-hodgkin’s lymphoma; and Aducanumab and E2609 for Alzheimer’s disease. Its Phase II clinical trial products include BIIB074 for trigeminal neuralgia, lumbosacral radiculopathy, and erythromelalgia; BAN2401 for Alzheimer’s disease; Opicinumab (anti-LINGO-1) for MS; TYSABRI for acute ischemic stroke; rAAV-XLRS for X-linked juvenile retinoschisis; BG00011 (STX-100) for idiopathic pulmonary fibrosis; and Dapirolizumab pegol and BIIB059 (Anti-BDCA02) for lupus. The company’s Phase I clinical trial products comprise BIIB061 for MS; BIIB054 for Parkinson’s disease; BIIB067 (IONIS-SOD1Rx) for amyotrophic lateral sclerosis; and BIIB068 (BTK Inhibitor) for autoimmune disease. It has collaboration agreements with AbbVie, Inc.; Acorda Therapeutics, Inc.; Applied Genetic Technologies Corporation; Eisai Co., Ltd.; Genentech, Inc.; Ionis Pharmaceuticals, Inc.; Samsung Bioepis; and University of Pennsylvania. Biogen Inc. offers products through its sales force and marketing groups. The company was formerly known as Biogen Idec Inc. and changed its name to Biogen Inc. in March 2015. Biogen Inc. was founded in 1978 and is headquartered in Cambridge, Massachusetts.

U.S. Bancorp (USB) saw its value increase by 0.78% as the stock gained $0.42 to finish the day at a closing price of $54.55. The stock was higher in trading and has fluctuated between $37.48-$54.6 per share for the past year. The shares, which traded within a range of $53.84 to $54.6 during the day, are up by 14.5% in the past three months and up by 28.44% over the past six months. It is currently trading 3.9% above its 20 day moving average and 5.27% above its 50 day moving average. Analysts believe the company can continue to increase in value to reach at $54 a share over the next twelve months. The current relative strength index (RSI) reading is 70.03.The technical indicator do not lead us to believe the stock will see more gains any time soon.

U.S. Bancorp, a financial services holding company, provides a range of financial services in the United States. It offers depository services, which include checking accounts, savings accounts, and time certificate contracts; and lending services, such as traditional credit products, as well as credit card services, leasing financing, import/export trade, asset-backed lending, agricultural finance, and other products. The company also provides ancillary services, including capital markets, treasury management, and receivable lock-box collection services to corporate customers; and a range of asset management and fiduciary services for individuals, estates, foundations, business corporations, and charitable organizations. In addition, it offers investment and insurance products to the company’s customers principally within its markets, as well as fund administration services to a range of mutual and other funds. Further, the company provides corporate and purchasing card, and corporate trust services; and merchant processing services, as well as offers cash and investment management, ATM processing, mortgage banking, and brokerage and leasing services. It serves individuals, businesses, institutional organizations, governmental entities, and other financial institutions. The company offers its services through a network of 3,133 banking offices primarily in the Midwest and West regions of the United States; and a network of 4,936 ATMs, as well as through on-line services and over mobile devices. U.S. Bancorp was founded in 1863 and is headquartered in Minneapolis, Minnesota.

 

3 Trending Stocks: Lincoln National Corporation (LNC), Celanese Corporation (CE), Fifth Third Bancorp (FITB)

Lincoln National Corporation (LNC) continued its upward trend with the stock climbing 1.48% or $1.05 to close the day at $72.13 on active trading volume of 2.24M shares, compared to its three month average trading volume of 1.57M. The Radnor Pennsylvania 19087 based company has been outperforming the life insurance group over the past 52 weeks, with the stock gaining 117.54%, compared to the industry which has advanced 47.61% over the same period. With RSI of 67.16, the stock should still continue to rise and get closer to its one year target estimate of $73.17, making it a hold for now.

Lincoln National Corporation, through its subsidiaries, engages in multiple insurance and retirement businesses in the United States. It operates through four segments: Annuities, Retirement Plan Services, Life Insurance, and Group Protection. The company sells a range of wealth protection, accumulation, and retirement income products and solutions. Its products include fixed and indexed annuities, variable annuities, universal life insurance (UL), variable universal life insurance (VUL), linked-benefit UL, term life insurance, indexed universal life insurance, and employer-sponsored retirement plans and services, as well as group life, disability, and dental products. Lincoln National Corporation also provides various plan investment vehicles, including individual and group variable annuities, group fixed annuities, and mutual fund-based programs; single and survivorship versions of UL and VUL, including corporate-owned UL and VUL, and bank-owned UL and VUL insurance products; and group non-medical insurance products, principally term life, universal life, disability, dental, vision, accident, and critical illness insurance to the employer market place through various forms of contributory and non-contributory plans. The company distributes its products through consultants, brokers, planners, agents, financial advisors, third-party administrators, and other intermediaries. Lincoln National Corporation was founded in 1904 and is headquartered in Radnor, Pennsylvania.

Celanese Corporation (CE) fell -0.05% during last trading as the stock lost $-0.04 to finish the day at $88.38 with about 1.03M shares changing hands, compared to its three month average trading volume of 860.53K. The $12.6B market cap company, which fluctuated between $87.57 and $88.48 during the day, currently situated 56.37% above its 52 week low of $57.49 and -0.61% away from its one year high of $88.92. The RSI of 65.28 indicates the stock is neither overvalued nor undervalued at the current levels, hold for now.

Celanese Corporation, a technology and specialty materials company, manufactures and sells value-added chemicals, thermoplastic polymers, and other chemical-based products worldwide. The company’s Advanced Engineered Materials segment develops, produces, and supplies specialty polymers for automotive and medical applications, as well as for use in industrial products and consumer electronics. Its Consumer Specialties segment provides cellulose acetate flakes, films, and tows for use in filtration applications; food protection ingredients, such as potassium sorbate and sorbic acid for food and beverage, and pharmaceutical industries; Sunett, a sweetener for use in various beverages, confections, and dairy products; and Qorus, a sweetener system designed for low-to no-calorie carbonated and non-carbonated beverages, flavored waters, energy drinks, and milk and dairy products. The company’s Industrial Specialties segment offers vinyl acetate-based emulsions for use in paints and coatings, adhesives, construction, glass fiber, textiles, and paper applications; and ethylene vinyl acetate resins and compounds, as well as low-density polyethylene for use in flexible packaging films, lamination film products, hot melt adhesives, medical products, automotive parts, and carpeting applications. Its Acetyl Intermediates segment produces and sells acetyl products, including acetic acid, vinyl acetate monomers, acetic anhydride, and acetate esters that are used as starting materials for colorants, paints, adhesives, coatings, and pharmaceuticals. The segment also provides organic solvents and intermediates for use in pharmaceutical, agricultural, and chemical products. The company was founded in 1918 and is headquartered in Irving, Texas.

Fifth Third Bancorp (FITB) saw its value increase by 3.03% as the stock gained $0.81 to finish the day at a closing price of $27.55. The stock was lighter in trading and has fluctuated between $14.56-$27.88 per share for the past year. The shares, which traded within a range of $26.64 to $27.58 during the day, are up by 13.16% in the past three months and up by 43.26% over the past six months. It is currently trading 4.32% above its 20 day moving average and 3.19% above its 50 day moving average. Analysts believe the company can continue to increase in value to reach at $27.47 a share over the next twelve months. The current relative strength index (RSI) reading is 60.4. The technical indicator lead us to believe there will be no major movement any time soon, hold.

Fifth Third Bancorp operates as a diversified financial services company in the United States. It operates through four segments: Commercial Banking, Branch Banking, Consumer Lending, and Investment Advisors. The Commercial Banking segment offers credit intermediation, cash management, and financial services; lending and depository products; and foreign exchange and international trade finance, derivatives and capital markets services, asset-based lending, real estate finance, public finance, commercial leasing, and syndicated finance for business, government, and professional customers. The Branch Banking segment provides deposit and loan products to individuals and small businesses. This segment offers checking and savings accounts, home equity loans and lines of credit, credit cards, and loans for automobiles and personal financing needs. The Consumer Lending segment engages in direct lending activities that include origination, retention, and servicing of residential mortgage and home equity loans or lines of credit; and indirect lending activities, including loans to consumers through correspondent lenders and automobile dealers. The Investment Advisors segment provides various investment alternatives for individuals, companies, and not-for-profit organizations. It offers retail brokerage services to individual clients; and broker dealer services to the institutional marketplace. This segment also provides asset management services; holistic strategies to affluent clients in wealth planning, investing, insurance, and wealth protection; and advisory services for institutional clients comprising states and municipalities. As of December 31, 2015, the company operated 1,254 full-service banking centers, including 95 Bank Mart locations, as well as 2,593 automated teller machines in 12 states throughout the Midwestern and Southeastern regions of the United States. Fifth Third Bancorp was founded in 1862 and is headquartered in Cincinnati, Ohio.

 

Stocks Buzz: American Tower Corporation (AMT), Vornado Realty Trust (VNO), Humana Inc. (HUM)

American Tower Corporation (AMT) failed to extend gains with the stock declining -0.72% or $-0.77 to close the day at $106.78 on light trading volume of 1.58M shares, compared to its three month average trading volume of 2.38M. The Boston Massachusetts 02116 based company has been outperforming the reit – diversified group over the past 52 weeks, with the stock gaining 26.03%, compared to the industry which has advanced 32.85% over the same period. With RSI of 59.1, the stock should still continue to rise and get closer to its one year target estimate of $129.8, making it a hold for now.

American Tower Corporation is a real estate investment trust. It invests in the real estate markets across the globe. The firm engages in leasing of space on multi-tenant communications sites to wireless service providers, radio and television broadcast companies, wireless data and data providers, government agencies and municipalities and tenants in a number of other industries. American Tower Corporation was founded in 1995 and is headquartered in Boston, Massachusetts.

Vornado Realty Trust (VNO) grew with the stock adding 2.42% or $2.58 to close at $109.03 on light trading volume of 1.37M compared its three months average trading volume of 934.89K. The New York New York 10019 based company operating under the REIT – Diversified industry has been trending up for the last 52 weeks, with the shares price now 35.84% up for the period and up by 5.16% so far this year. With price target of $110.45 and a 38.49% rebound from 52-week low, Vornado Realty Trust has plenty of upside potential, making it a hold with a view buy.

Vornado Realty Trust is a publicly owned real estate investment trust. The firm invests in the real estate markets of the United States. It makes investments in commercial real estate properties to create its portfolio. The firm was formerly known as Vornado Inc. Vornado Realty Trust is based in New York City with additional offices in Arlington, Virginia; and Paramus, New Jersey.

Humana Inc. (HUM) failed to extend gains with the stock declining -0.35% or $-0.73 to close the day at $205.97 on higher than average trading volume of 2.23M shares, compared to its three month average trading volume of 1.63M. The Louisville Kentucky 40202 based company has been outperforming the health care plans companies by 6.6779% for last three months and its recent gains have pushed the stock slightly up 1.1% YTD, versus the health care plans industry which is up 3.71% for the same period. The RSI of 56.57 indicates the stock is neither overvalued nor undervalued at the current levels, hold for now.

Humana Inc., together with its subsidiaries, operates as a health and well-being company. The company operates through three segments: Retail, Group, and Healthcare Services. The Retail segment offers Medicare, and commercial fully-insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products directly to individuals. This segment also has contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. The Group segment provides commercial fully-insured medical and specialty health insurance benefits comprising dental, vision, and other supplemental health and voluntary insurance benefits; and administrative services only, and health and wellness products to employer groups. It also offers military services, such as TRICARE South Region contract. The Healthcare Services segment offers pharmacy solutions, provider services, home based services, clinical programs, and predictive modeling and informatics services to its health plan members, as well as to third parties. The company also provides closed-block long-term care insurance policies. As of December 31, 2015, it had approximately 14.2 million members in medical benefit plans, as well as approximately 7.2 million members in specialty products. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.

 

Momentum Stocks in Focus: Intuit Inc. (INTU), Welltower Inc. (HCN), PG&E Corporation (PCG)

Intuit Inc. (INTU) continued its upward trend with the stock climbing 0.37% or $0.44 to close the day at $118.84 on active trading volume of 1.48M shares, compared to its three month average trading volume of 1.17M. The Mountain View California 94043 based company has been outperforming the application software group over the past 52 weeks, with the stock gaining 26.07%, compared to the industry which has advanced 29.41% over the same period. With RSI of 57.52, the stock should still continue to rise and get closer to its one year target estimate of $116.88, making it a hold for now.

Intuit Inc. provides business and financial management solutions for small businesses, consumers, and accounting professionals primarily in the United States and internationally. The company’s Small Business segment provides QuickBooks financial and business management online services, and desktop software; QuickBooks technical support services; financial supplies; and QuickBooks Online Accountant, QuickBooks Accountant Desktop, and QuickBooks Desktop Accountant Plus, as well as the QuickBooks ProAdvisor Program for the accounting professionals. This segment also offers small business payroll products and services, including online payroll offerings, such as Quickbooks Online Payroll and Intuit Online Payroll; desktop payroll offerings comprising QuickBooks Basic Payroll and QuickBooks Enhanced Payroll; and full service payroll offerings, such as Intuit Full Service Payroll and QuickBooks Assisted Payroll. In addition, it provides merchant services, including credit and debit card processing; Web-based transaction processing services for online merchants; online payment services; GoPayment mobile payment processing services; and QuickBooks point of sale solutions. Its Consumer segment provides TurboTax income tax preparation products and services; and electronic tax filing services. The company’s Professional Tax segment offers Lacerte, ProSeries, ProFile, and Intuit Tax Online professional tax products and services; and electronic tax filing services, bank product transmission services, and training services. The company sells its products and services through various sales and distribution channels, including Websites, promotions, call centers, retail locations, and online mobile application stores, as well as through alliance partners, such as banks, credit unions, and other financial institutions. Intuit Inc. was founded in 1983 and is headquartered in Mountain View, California.

Welltower Inc. (HCN) retreated with the stock falling -1.18% or $-0.78 to close at $65.51 on light trading volume of 1.35M compared its three months average trading volume of 2.08M. The Toledo Ohio 43615 based company operating under the REIT – Healthcare Facilities industry has been trending up for the last 52 weeks, with the shares price now 22.97% up for the period and down by -0.82% so far this year. With price target of $69.39 and a 26.54% rebound from 52-week low, Welltower Inc. has plenty of upside potential, making it a hold with a view buy.

Welltower Inc. is an independent equity real estate investment trust. The firm engages in acquiring, planning, developing, managing, repositioning and monetizing of real estate assets. It primarily invests in the real estate markets of the United States. The firm primarily invests in senior living and health care properties. It invests across the full spectrum of health care real estate, including senior living communities, medical office buildings, inpatient and outpatient medical centers and life science facilities. The firm conducts in-house research to make its investments. It was formerly known as Health Care REIT, Inc. Welltower Inc. was founded in 1970 and is based in Toledo, Ohio with additional offices in Brentwood, Tennessee and Dallas, Texas.

PG&E Corporation (PCG) failed to extend gains with the stock declining -0.58% or $-0.37 to close the day at $63.32 on lower than average trading volume of 2.01M shares, compared to its three month average trading volume of 2.1M. The San Francisco California 94177 based company has been outperforming the electric utilities companies by 9.0801% for last three months and its recent gains have pushed the stock slightly up 4.2% YTD, versus the electric utilities industry which is up 1.73% for the same period. The RSI of 64.76 indicates the stock is neither overvalued nor undervalued at the current levels, hold for now.

PG&E Corporation, through its subsidiary, Pacific Gas and Electric Company, transmits, delivers, and sells electricity and natural gas to residential, commercial, industrial, and agricultural customers primarily in northern and central California. The company’s electricity distribution network consists of approximately 142,000 circuit miles of distribution lines, 58 transmission switching substations, and 603 distribution substations; and electricity transmission network comprises approximately 18,400 circuit miles of interconnected transmission lines and 91 electric transmission substations. Its natural gas system consists of approximately 42,800 miles of distribution pipelines, approximately 6,700 miles of backbone and local transmission pipelines, and various storage facilities. The company operates various electricity generation facilities, such as nuclear, hydroelectric, fossil fuel-fired, and photovoltaic. PG&E Corporation was founded in 1905 and is headquartered in San Francisco, California.

 

Stocks on Trader’s Radar: Cerner Corporation (CERN), Exelon Corporation (EXC), Stryker Corporation (SYK)

Cerner Corporation (CERN) continued its upward trend with the stock climbing 3.87% or $2.03 to close the day at $54.55 on active trading volume of 4.69M shares, compared to its three month average trading volume of 3.24M. The North Kansas City Missouri 64117 based company has been underperforming the healthcare information services group over the past 52 weeks, with the stock losing -1.64%, compared to the industry which has advanced 13.46% over the same period. With RSI of 61.89, the stock should still continue to rise and get closer to its one year target estimate of $59.7, making it a hold for now.

Cerner Corporation designs, develops, markets, installs, hosts, and supports health care information technology, health care devices, hardware, and content solutions for health care organizations and consumers in the United States and internationally. The company offers Cerner Millennium architecture, which includes clinical, financial, and management information systems that allow providers to access an individual’s electronic health record at the point of care, and organizes and delivers information for physicians, nurses, laboratory technicians, pharmacists, front- and back-office professionals, and consumers. It also provides HealtheIntent platform, a cloud-based platform that enables organizations to aggregate, transform, and reconcile data across the continuum of care, as well as assists to enhance outcomes and lower costs. In addition, the company offers a portfolio of clinical and financial health care information technology solutions, as well as departmental, connectivity, population health, and care coordination solutions; and various complementary services, including support, hosting, managed, implementation, and strategic consulting services. Further, it provides various services, such as implementation and training, remote hosting, operational management, revenue cycle, support and maintenance, health care data analysis, clinical process optimization, transaction processing, employer health centers, employee wellness programs, and third party administrator services for employer-based health plans; and complementary hardware and devices for third parties. It serves integrated delivery networks, physician groups and networks, managed care organizations, hospitals, medical centers, reference laboratories, home health agencies, blood banks, imaging centers, pharmacies, pharmaceutical manufacturers, employers, governments, and public health organizations. Cerner Corporation was founded in 1979 and is headquartered in North Kansas City, Missouri.

Exelon Corporation (EXC) climbed 0.74% during last trading as the stock added $0.26 to finish the day at $35.36 with about 5.54M shares changing hands, compared to its three month average trading volume of 6.21M. The $32.49B market cap company, which fluctuated between $34.91 and $35.51 during the day, currently situated 20.56% above its 52 week low of $29.82 and -3.51% away from its one year high of $37.7. The RSI of 53.72 indicates the stock is neither overvalued nor undervalued at the current levels, hold for now.

Exelon Corporation, a utility services holding company, engages in the energy generation and delivery businesses in the United States and Canada. It owns electric generating facilities, such as nuclear, fossil, and hydroelectric generation facilities, as well as wind and solar facilities. The company also sells renewable energy and other energy-related products and services; and engages in natural gas and oil exploration and production activities, as well as sells electricity and natural gas to wholesale and retail customers. In addition, it is involved in the purchase and regulated retail sale of electricity, and the provision of electricity transmission and distribution services to retail customers in northern Illinois, southeastern Pennsylvania, and central Maryland. Further, the company engages in the purchase and regulated retail sale of natural gas, and the provision of gas distribution services to retail customers in the Pennsylvania counties surrounding the City of Philadelphia, as well as in central Maryland, including the City of Baltimore. It serves distribution utilities, municipalities, cooperatives, and financial institutions, as well as commercial, industrial, governmental, and residential customers. The company was founded in 1887 and is headquartered in Chicago, Illinois.

Stryker Corporation (SYK) saw its value increase by 0.75% as the stock gained $0.93 to finish the day at a closing price of $125.26. The stock was lighter in trading and has fluctuated between $95.79-$127.23 per share for the past year. The shares, which traded within a range of $123.84 to $125.51 during the day, are up by 13.9% in the past three months and up by 9.44% over the past six months. It is currently trading 2.21% above its 20 day moving average and 4.49% above its 50 day moving average. Analysts believe the company can continue to increase in value to reach at $130.95 a share over the next twelve months. The current relative strength index (RSI) reading is 69.64. The technical indicator lead us to believe there will be no major movement any time soon, hold.

Stryker Corporation, together with its subsidiaries, operates as a medical technology company. It operates through three segments: Orthopaedics; MedSurg; and Neurotechnology and Spine. The Orthopaedics segment offers implants for use in hip and knee joint replacements, and trauma and extremities surgeries. The MedSurg segment provides surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, and reprocessed and remanufactured medical devices, as well as other medical devices for use in various medical specialties. The Neurotechnology and Spine segment offers neurosurgical and neurovascular devices that include products used for minimally invasive endovascular techniques; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, including synthetic bone grafts and vertebral augmentation products; and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke. This segment also provides spinal implant products, which consists of cervical, thoracolumbar, and interbody systems for use in spinal injury, deformity, and degenerative therapies. The company markets and sells its products to doctors, hospitals, and other healthcare facilities through company-owned sales subsidiaries and branches, as well as third-party dealers and distributors in approximately 100 countries. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan.

 

3 Stocks to Watch For: Maxim Integrated Products, Inc. (MXIM), Xilinx, Inc. (XLNX), Medtronic plc (MDT)

Maxim Integrated Products, Inc. (MXIM) saw its value decrease by -0.89% as the stock dropped $-0.4 to finish the day at a closing price of $44.63. The stock was lighter in trading and has fluctuated between $31.56-$45.58 per share for the past year. The shares, which traded within a range of $44.57 to $45.13 during the day, are up by 15.57% in the past three months and up by 10.68% over the past six months. It is currently trading 2.58% above its 20 day moving average and 9.02% above its 50 day moving average. Analysts believe the company can continue to increase in value to reach at $46.35 a share over the next twelve months. The current relative strength index (RSI) reading is 64.02.The technical indicator lead us to believe there will be no major movement any time soon, hold.

Maxim Integrated Products, Inc. designs, develops, manufactures, and markets various linear and mixed-signal integrated circuits in the United States, China, other countries in Asia, Europe, and internationally. It also provides a range of high-frequency process technologies and capabilities for use in custom designs. The company serves automotive, communications and data center, computing, consumer, and industrial markets. It markets its products through a direct-sales and applications organization, as well as through its own and other unaffiliated distribution channels. Maxim Integrated Products, Inc. was founded in 1983 and is headquartered in San Jose, California.

Xilinx, Inc. (XLNX) shares were down in last trading by -1.28% to $58.75. It experienced lighter than average volume on day. The stock increased in value by almost 1.14% over the past week and grew 0.98% in the past month. It is currently trading 1.58% above its 50 day moving average and 14.72% above its 200 day moving average. Following the recent decrease in price, the stock’s new closing price represents a -5.07% decrease in value from its one year high of $62.24. The RSI indicator value of 54.96, lead us to believe that it is a hold for now.

Xilinx, Inc. designs and develops programmable devices and associated technologies worldwide. Its programmable devices comprise integrated circuits (ICs) in the form of programmable logic devices (PLDs), such as programmable system on chips, and three dimensional ICs; software design tools to program the PLDs; targeted reference designs; printed circuit boards; and intellectual property (IP). The company also offers development boards; development kits, including hardware, design tools, IP, and reference designs that are designed to streamline and accelerate the development of domain-specific and market-specific applications; and configuration products, such as one-time programmable and in-system programmable storage devices to configure field programmable gate arrays. In addition, it provides design services, customer training, field engineering, and technical support. The company offers its products to electronic equipment manufacturers in end markets, such as wired and wireless communications, industrial, scientific and medical, aerospace and defense, audio, video and broadcast, consumer, automotive, and test and measurement. Xilinx, Inc. sells its products through a network of independent distributors; and through direct sales to original equipment manufacturers and electronic manufacturing service providers by a network of independent sales representative firms and by a direct sales management organization. The company was founded in 1984 and is headquartered in San Jose, California.

Medtronic plc (MDT) traded within a range of $76.46 to $77.3 after opening the day at $77. The company has seen its stock increase in value by 8.17% so far this year. The stock was up close to 0.17% on light volume in last trading session and closed at $77.05 per share. After the recent gain, the stock is currently holding -13.17% below its 52 week high of $89.27 and 11.1% above its 12-month low of $69.35. The shares are down by over -5.56% in the last three months, and the RSI indicator value of 65.64 is neither bullish nor bearish, tempting investors to stay on the sidelines.

Medtronic plc manufactures and sells device-based medical therapies worldwide. The company’s Cardiac and Vascular Group segment offers pacemakers, implantable cardioverter defibrillators and cardiac resynchronization therapy devices, AF products, diagnostics and monitoring devices, and remote monitoring and patient-centered software; and heart valves, percutaneous coronary intervention stent products, surgical valve replacement and repair products, endovascular stent grafts, peripheral vascular intervention products, and products to treat superficial and deep venous diseases. Its Minimally Invasive Therapies Group segment provides gastrointestinal diagnostics, ablation, and interventional lung solutions; stapling, vessel sealing, and other surgical instruments; sutures; electrosurgery products; hernia mechanical devices; mesh implants; products for patient monitoring and recovery; sensors; monitors; compression and dialysis, enteral feeding, and wound care products; and operating room supplies, electrodes, needles, syringes, and sharps disposals. The company’s Restorative Therapies Group segment offers products for various areas of the spine; bone graft substitutes; biologic products; trauma, implantable neurostimulation therapies, and drug delivery systems for the treatment of chronic pain, movement disorders, obsessive-compulsive disorder, overactive bladder, urinary retention, fecal incontinence, and gastroparesis; products to treat conditions of the ear, nose, throat, and neurological disorders; systems that incorporate advanced energy surgical instruments; products for haemostatic sealing of soft tissue and bone; and image-guided surgery and intra-operative imaging systems. Its Diabetes Group segment provides insulin pumps and consumables; continuous glucose monitoring systems; and Web-based therapy management software solutions. It serves hospitals, physicians, clinicians, and patients. Medtronic plc was founded in 1949 and is headquartered in Dublin, Ireland.

 

Stocks in Review: AMETEK, Inc. (AME), CBRE Group, Inc. (CBG), International Paper Company (IP)

AMETEK, Inc. (AME) traded within a range of $53.2 to $53.63 after opening the day at $53.48. The company has seen its stock increase in value by 10.25% so far this year. The stock was down close to -0.17% on active volume in last trading session and closed at $53.58 per share. After the recent fall, the stock is currently holding -0.58% below its 52 week high of $53.89 and 24.26% above its 12-month low of $43.28. The shares are up by over 13.54% in the last three months, and the RSI indicator value of 72.17 is bearish. The technical indicator is offering a warning sign that the stock can’t keep current pace going.

AMETEK, Inc. manufactures electronic instruments and electromechanical devices worldwide. Its Electronic Instruments Group segment provides advanced instruments for the process, aerospace, power, and industrial markets; process and analytical instruments for the oil, gas, petrochemical, pharmaceutical, semiconductor, and factory automation markets; instruments for the laboratory equipment, ultra precision manufacturing, medical, and test and measurement markets; and vision systems for surface inspection. This segment also offers aircraft and engine sensors, monitoring systems, power instruments, data acquisition units, and fuel and fluid measurement systems for the aerospace industry; power quality monitoring and metering devices, industrial battery chargers, uninterruptible power supplies, programmable power and electrical test equipment, and gas turbine sensors; and dashboard instruments for heavy trucks and other vehicles, as well as timing controls and cooking computers for the food service industry. Its Electromechanical Group segment provides electrical interconnects, specialty metals, thermal management systems, and floor care and specialty motors; precision motion control products for data storage, medical devices, business equipment, factory automation, and other applications; engineered electrical connectors and packaging products to protect sensitive electronic devices; and metal tubing products. This segment also offers high-purity metals, metal strips, shaped wires, and advanced composites for various industrial applications; and motors used in commercial appliances, fitness equipment, food and beverage machines, hydraulic pumps, industrial blowers, and vacuum cleaners; and operates a network of aviation maintenance, repair, and overhaul facilities. In addition, it offers mission critical communication solutions for hospitals, healthcare systems, and educational facilities. AMETEK, Inc. was founded in 1930 and is headquartered in Berwyn, Pennsylvania.

CBRE Group, Inc. (CBG) continued its upward trend with the stock climbing 1.86% or $0.64 to close the day at $35.13 on active trading volume of 2.2M shares, compared to its three month average trading volume of 2.14M. The Los Angeles California 90071 based company has been outperforming the property management group over the past 52 weeks, with the stock gaining 44.45%, compared to the industry which has advanced 23.94% over the same period. With RSI of 76.89, the stock should still continue to rise and get closer to its one year target estimate of $34.14, making it a hold for now.

CBRE Group, Inc. operates as a commercial real estate services and investment company worldwide. It operates through Americas; Europe, Middle East and Africa; Asia Pacific; Global Investment Management; and Development Services segments. The company offers advisory services, such as strategic advice and execution to owners, investors, and occupiers of real estate in connection with leasing, disposition, and acquisition of property; integrated investment sales and debt/structured financing services under the CBRE Capital Markets brand; and valuation services, including market value appraisals, litigation support, discounted cash flow analyses, feasibility and fairness opinions, property condition reports, hotel advisory, and environmental consulting, as well as originates and services commercial mortgage loans. It also provides outsourcing services comprising facilities management, project management, advisory and transaction, and strategic consulting services to occupiers of real estate; and property management services consisting of construction management, marketing, building engineering, accounting, and financial services for owners/investors in office, industrial, and retail properties. In addition, the company offers investment management services to pension funds, insurance companies, sovereign wealth funds, foundations, endowments, and other institutional investors seeking to generate returns and diversification through investment in real estate. Further, the company develops and invests in commercial real estate, including industrial, office, and retail properties; healthcare facilities; and residential/mixed-use projects. CBRE Group, Inc. offers its commercial real estate services under the CBRE brand name; investment management services under the CBRE Global Investors brand name; and development services under the Trammell Crow brand name. The company was founded in 1906 and is headquartered in Los Angeles, California.

International Paper Company (IP) gained $0.2 to close the day at a new closing price of $52.88, a 0.38% increase in value from its previous closing price that moved the stock 64.49% above its 52 week low of $33.43. A total of 2.89M shares exchanged hands during the day compared with its three month average trading volume of 3.02M. The stock, which fluctuated between $52.33 and $52.92 during the day, currently situated -9.37% below its 52 week high. The stock is down by -0.38% in the past one month and up by 16.84% over the past three months. With a one year target estimate of $54.4 and RSI of 47.36, the stock still has upside potential, making it a hold for now.

International Paper Company operates as a paper and packaging company in North America, Europe, Latin America, Russia, Asia, Africa, and the Middle East. The company operates through three segments: Industrial Packaging, Printing Papers, and Consumer Packaging. The Industrial Packaging segment manufactures containerboards, including linerboard, medium, whitetop, recycled linerboard, recycled medium, and saturating kraft. The Printing Papers segment produces printing and writing papers, such as uncoated papers for end use applications, including brochures, pamphlets, greeting cards, books, annual reports, and direct mail, as well as envelopes, tablets, business forms, and file folders. This segment sells uncoated papers under the Hammermill, Springhill, Williamsburg, Postmark, Accent, Great White, Chamex, Ballet, Rey, Pol, and Svetocopy brand names. It also produces pulp for manufacturing printing, writing, and specialty papers, as well as towels and tissues, filtration products, diapers, and sanitary napkins. The Consumer Packaging segment offers coated paperboards for various packaging and foodservice end uses, such as food, cosmetics, pharmaceuticals, and tobacco products under the Everest, Fortress, and Starcote brand names. This segment also produces cups, lids, food containers, and plates. The company sells its packaging products, paper products, and other products directly to end users and converters, as well as through agents, resellers, and paper distributors. International Paper Company was founded in 1898 and is headquartered in Memphis, Tennessee.